CC
MLAB icon

Centiva Capital’s Mesa Laboratories MLAB Stock Holding History

Centiva Capital’s Portfolio MLAB Stock Details MLAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-2,634
Closed -$342K – 2129
2024
Q3 		$342K Sell
2,634
-1,109
-30% -$130K 0.01% 1498
2024
Q2 		$325K Buy
+3,743
New +$392K 0.01% 1418
2021
Q4 		– Sell
-667
Closed -$202K – 1415
2021
Q3 		$202K Sell
667
-719
-52% -$204K 0.01% 925
2021
Q2 		$376K Buy
+1,386
New +$352K 0.01% 949
2020
Q3 		– Sell
-1,065
Closed -$231K – 809
2020
Q2 		$231K Buy
+1,065
New +$245K 0.01% 477

Other funds holding MLAB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.58B AUM 51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.36B AUM 17.81% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Centiva Capital's MLAB Position: Q4 2024 in Review

Centiva Capital sold out of Mesa Laboratories (MLAB) in Q4 2024, closing a stake of 2,634 shares — an estimated $342K sold.

Centiva Capital first reported a position in MLAB in Q2 2020 and held it in 5 quarters. The position peaked at $376K in Q2 2021. 156 funds tracked by Wall St. Rank hold MLAB as of Q4 2024.

  • Centiva Capital reported no remaining Mesa Laboratories position as of Q4 2024 after selling out during the quarter.
  • Centiva Capital sold 2,634 Mesa Laboratories shares in Q4 2024, an estimated $342K.
  • Centiva Capital first reported a position in Mesa Laboratories in Q2 2020 and held it in 5 quarters.
  • Centiva Capital's Mesa Laboratories position peaked at $376K in Q2 2021.
  • 156 funds tracked by Wall St. Rank held Mesa Laboratories as of Q4 2024.

Based on Centiva Capital's 13F filing for Q4 2024, filed 14 Feb 2025.